Euticals Group has completed the acquisition of Italian pharmaceutical fine chemical company, Archimica Group, The Wall Street Journal reports. Euticals has bought the pharmaceutical group from U.S. private equity firm, TowerBrook Capital.

The financial details of the transaction were not disclosed by both the parties. TowerBrook bought Archimica, which has about 550 employees at six production sites in Italy, France, Germany, U.S. and U.K., in June 2006.

Click here for the story from The Wall Street Journal.